BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Rhea-AI Summary

BioHarvest Sciences (NASDAQ: BHST) has announced its participation in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference on December 3, 2024, in Boca Raton, FL. CEO Ilan Sobel will conduct one-on-one meetings with institutional investors and deliver a presentation at the event. The company, which specializes in Botanical Synthesis technology, aims to discuss its growth strategy focusing on plant-based molecules for Direct-to-Consumer Health and Wellness business and CDMO customers. The presentation will be made available on BioHarvest's investor relations website following the conference.

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place on December 3, 2024.

CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event and will host a presentation for in-person attendees. Following the conference, a link to the presentation will be shared on the BioHarvest investor relations website.

Noble 20th Annual Emerging Growth Conference
Date: Tuesday, December 3, 2024
Location: Florida Atlantic University - Boca Raton, FL

Sobel said: "I am pleased to announce our attendance at the upcoming Noble Capital Markets Emerging Growth Equity Conference. We have received a very positive response following our recent Nasdaq listing, and I look forward to meeting with institutional investors to discuss how BioHarvest is executing on our growth strategy to develop and commercialize plant-based molecules for both our Direct-to-Consumer Health and Wellness business, and for our CDMO customers."

Registration is mandatory for conference participation. For more information or to schedule a meeting with management, please contact MZ Group at BHSC@mzgroup.us.

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow the active ingredients in plants, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.

Forward-Looking Statements

Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance of additional future contracts. Readers are cautioned that future contracts or increased revenue is not necessarily an increase in net income or profitability as costs will likely increase as well. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.

This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibility for its contents.

BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations & Director
(604) 622-1186
info@bioharvest.com

Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
(949) 259-4987
BHSC@mzgroup.us

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/230852

FAQ

When is BioHarvest Sciences (BHST) presenting at the Noble Capital Markets Conference?

BioHarvest Sciences (BHST) is presenting at the Noble Capital Markets Conference on December 3, 2024, at Florida Atlantic University in Boca Raton, FL.

What will BioHarvest Sciences (BHST) discuss at the Noble Capital Markets Conference?

BioHarvest Sciences will discuss its growth strategy for developing and commercializing plant-based molecules for Direct-to-Consumer Health and Wellness business and CDMO customers.

How can investors attend BioHarvest Sciences' (BHST) presentation at the Noble Conference?

Investors must register to participate in the conference and can schedule meetings with management by contacting MZ Group at BHSC@mzgroup.us.

Where can investors find BioHarvest Sciences' (BHST) Noble Conference presentation?

The presentation will be available on BioHarvest's investor relations website following the conference on December 3, 2024.